Loading...
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
In a phase I study we demonstrated the feasibility of a bi-weekly combination of paclitaxel 180 mg m(−2) with cisplatin 60 mg m(−2). In this study we further assessed toxicity and efficacy of this schedule in the treatment of advanced cancer of the oesophagus or the gastro-oesophageal junction. Pati...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2002
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2375296/ https://ncbi.nlm.nih.gov/pubmed/11875723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600166 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|